Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences has informed BSE that its Board of Directors will meet on January 23, 2026 to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2025. The notice was filed on January 19, 2026 in compliance with SEBI Listing Regulations. No financial figures or business details have been shared in this notice. The actual results are expected to be disclosed after the board meeting on the scheduled date.
This is a routine pre-results intimation with no direct impact on shareholders. Investors should watch for the actual Q3 and 9MFY26 numbers to be released post the board meeting on January 23, 2026.